Copper(II) complexes demonstrate significant DNA binding and cytotoxicity in cancer cells, indicating potential therapeutic applications.
Synthesis of the first example of metal complexes containing Schiff‐base ligands derived from amino acids and aldehyde with N‐oxide functionality is presented. Five copper(II) complexes with the compositions [Cu(L 1 )(H 2 O)(OAc)]⋅H 2 O ( 1 ), [Cu 3 (L 2 ) 2 Cl 4 (H 2 O) 2 ] ( 2 ), [Cu 4 (L 2 ) 2 Cl 6 (MeOH) 2 ] ( 3 ), [Cu 2 (L 3 )Cl 3 (H 2 O)] ( 4 ), and [Cu 3 (L 3 ) 2 Cl 3 (H 2 O) 3 ]Cl ( 5 ) (where anionic ligands L 1 – L 3 are Schiff bases obtained by condensation of 2‐pyridinecarbaldehyde N‐oxide with 2‐aminoisobutyric acid (HL 1 ), β‐alanine (HL 2 ), and 3‐aminobutanoic acid (HL 3 )) were prepared by template synthesis and fully crystallographically characterized. Complexes 1 – 4 were examined for DNA interactions, competitive studies with EB‐DNA, viscosity measurements, DNA cleavage studies, cytotoxicity studies, interactions with bovine serum albumin (BSA), and theoretical docking studies. The studied complexes bind to the helix through a nonintercalative binding mode; the interaction of complexes with ctDNA is predominantly via intercalation, while viscosity measurements indicate mostly groove binding. DNA cleavage studies revealed the highest cleavage activity for complex 1 . The MTT assay on three human cell lines shows the highest cytotoxic effect for complex 1 against HepG2 (human liver cancer cell line). Experimental interaction of studied complexes with BSA indicates an intermediate binding strength between complexes and albumin, while theoretical docking studies identify possible binding sites of complexes within the BSA.
No takes yet. Share an insight, caveat, or question.
Valentová et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: